2 completed, 1 active not recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Active not recruiting 1 |
Follow ELLIPTA: new trials by email Literature Review of ELLIPTA trials Research Report on ELLIPTA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma FF/UMEC/VI, ELLIPTA, FF/VI - Asthma | Phase 3 | Active not recruiting | GlaxoSmithKline | 138 | 2023-04-24 | 2026-11-04 |
| Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled Asthma FF/VI, FF/UMEC/VI, ELLIPTA - Asthma | Phase 3 | Completed | GlaxoSmithKline | 359 | 2021-07-29 | 2025-08-11 |
| DISKUS vs. ELLIPTA Device Preference Study in Chronic Obstructive Pulmonary Disease (COPD) ELLIPTA, DISKUS - Pulmonary Disease, Chronic Obstructive | Phase 3 | Completed | GlaxoSmithKline | 287 | 2013-05-01 | 2014-03-04 |
Asthma (2) · Pulmonary Disease, Chronic Obstructive (1)
GlaxoSmithKline (3)
United States (2) · Argentina (1) · Australia (1) · Chile (1) · China (1) · Israel (1) · Mexico (1) · New Zealand (1) · South Korea (1) · Turkey (Türkiye) (1)